She is a pediatric neurologist with post-doctoral training in developmental cognitive neuroscience, and has a particular interest in pursuing electrophysiological biomarkers in autism spectrum disorders (ASD). Her lab uses high density EEG and eye tracking to define cognitive phenotypes in young children with ASD and other neurodevelopmental disorders. She uses innovative methods to define predictors of outcome in the perceptual and cognitive domains of children with limited verbal abilities. Her lab is studying three main populations: (1) toddlers and preschoolers with ASD who are enrolled in an intensive treatment program at UCLA; (2) infants at high-risk for an ASD based on having an older sibling with ASD; and (3) infants with tuberous sclerosis complex, a genetic disorder associated with a high rate of ASD.